CONSIDERATIONS TO KNOW ABOUT TEMAZEPAM

glycerol phenylbutyrate will reduce the extent or result of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Glycerol phenylbutyrate is actually a weak inducer of CYP3A4. Monitor for diminished efficacy of CYP3A4 substrates that have a narrow therapeutic index.Tolerance to estazolam might acquire from